Vetra Bio


Vetra Bio venture logo.

Programme

Pre-Accelerate Cambridge

Sector

Healthcare/Pharma/Biotech


We are building an AI-driven platform to reverse biological ageing and extend the healthy lifespan of animals. Our work is grounded in studying naturally occurring age-related diseases in real animal populations – including dogs, cats, and horses, rather than artificial laboratory models. By analysing blood-derived DNA and epigenetic data across species, we use AI to identify conserved ageing mechanisms that drive functional decline. As an initial commercial entry point, we are developing a blood-based biological age and risk profiling service for pets, enabling early detection of age-related co-morbidities and personalised health recommendations, while generating the longitudinal data needed to accelerate development of healthspan-extending interventions.

Top